Agios Pharmaceuticals (AGIO) Current Deferred Revenue (2012 - 2022)
Agios Pharmaceuticals' Current Deferred Revenue was $2.5 million in Q1 2022.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Current Deferred Revenue (2012 - 2022) Analysis & Trends
At the end of FY2019, Current Deferred Revenue at Agios Pharmaceuticals came in at $10.93 million, down 66.6% from FY2018.
- Current Deferred Revenue shows a five-year compound annual growth rate of -21.1% (FY2014 to FY2019).
- In earlier years, Current Deferred Revenue was $32.71 million in FY2018 (-13.6%), $37.84 million in FY2017 (+5.4%), $35.91 million in FY2016 (+82.6%) and $19.67 million in FY2015 (-44.9%).
- The Q1 2022 figure marks the highest quarterly Current Deferred Revenue in data going back to Q4 2012.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2017 (growth of 17.8%); the worst was Q1 2020 (a decline of 78.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 2.50 Mn |
| Mar 31, 2020 | 4.75 Mn |
| Dec 31, 2019 | 10.93 Mn |
| Sep 30, 2019 | 16.87 Mn |
| Jun 30, 2019 | 18.45 Mn |
| Mar 31, 2019 | 22.17 Mn |
| Dec 31, 2018 | 32.71 Mn |
| Sep 30, 2018 | 42.14 Mn |
| Jun 30, 2018 | 41.13 Mn |
| Mar 31, 2018 | 39.21 Mn |
| Dec 31, 2017 | 37.84 Mn |
| Sep 30, 2017 | 35.87 Mn |
| Jun 30, 2017 | 37.07 Mn |
| Mar 31, 2017 | 37.69 Mn |
| Dec 31, 2016 | 35.91 Mn |
| Sep 30, 2016 | 36.42 Mn |
| Jun 30, 2016 | 31.47 Mn |
| Mar 31, 2016 | 16.52 Mn |
| Dec 31, 2015 | 19.67 Mn |
| Sep 30, 2015 | 22.65 Mn |
API Access
Agios Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();